Citations

Clear

4847 citation(s) found for "Tu, Eric".

Focus Issue: Neck Dissection for Oropharyngeal Squamous Cell Carcinoma
Moore, Eric J. , Abel, Kathryn M. Van

Mayo Clinic

ISRN Surgery | January 15, 2012 | Volume: 2012 | Issue: No issue available | Pages: 1-10

10.5402/2012/547017 | PMID 22586518 Get It

The staging and prognosis of oropharyngeal squamous cell carcinoma is intimately tied to the status of the cervical lymph nodes. Due to the high risk for occult nodal disease, most clinicians recommend treating the neck for these primary tumors. While there are many modalities available, surgical resection of nodal disease offers both a therapeutic and a diagnostic intervention. We review the relevant anatomy, nodal drainage patterns, clinical workup, surgical management and common complications associated with neck dissection for oropharyngeal squamous cell carcinoma.
Candidate Serum Biomarkers for Prostate Adenocarcinoma Identified by mRNA Differences in Prostate Tissue and Verified with Protein Measurements in Tissue and Blood
Klee, Eric W. , Bondar, Olga P., Goodmanson, Marcia K., Dyer, Roy B. , Erdoğan, Sibel , Bergstralh, Eric J., H., Robert Bergen, Sebo, Thomas J., Klee, George G.

Mayo Clinic

Clinical Chemistry | January 13, 2012 | Volume: 58 | Issue: 3 | Pages: 599-609

10.1373/clinchem.2011.171637 | PMID 22247499 Get It

Abstract BACKGROUND Improved tests are needed for detection and management of prostate cancer. We hypothesized that differential gene expression in prostate tissue could help identify candidate blood biomarkers for prostate cancer and that blood from men with advanced prostate disease could be used to verify the biomarkers presence in circulation. METHODS We identified candidate markers using mRNA expression patterns from laser-capture microdissected prostate tissue and confirmed tissue expression using immunohistochemistry (IHC) for the subset of candidates having commercial antisera. We analyzed tissue extracts with tandem mass spectrometry (MS/MS) and measured blood concentrations using immunoassays and MS/MS of trypsin-digested, immunoextracted peptides. RESULTS We selected 35 novel candidate prostate adenocarcinoma biomarkers. For all 13 markers having commercial antisera for IHC, tissue expression was confirmed; 6 showed statistical discrimination between nondiseased and malignant tissue, and only 5 were detected in tissue extracts by MS/MS. Sixteen of the 35 candidate markers were successfully assayed in blood. Four of 8 biomarkers measured by ELISA and 3 of 10 measured by targeted MS showed statistically significant increases in blood concentrations of advanced prostate cancer cases, compared with controls. CONCLUSIONS Seven novel biomarkers identified by gene expression profiles in prostate tissue were shown to have statistically significant increased concentrations in blood from men with advanced prostate adenocarcinoma compared with controls: apolipoprotein C1, asporin, cartilage oligomeric matrix protein, chemokine (C-X-C motif) ligand 11 (CXCL11), CXCL9, coagulation factor V, and proprotein convertase subtilisin/kexin 6.
P2‐191: Investigating the association between fasting serum glucose levels and cerebral metabolic rate for glucose in brain regions affected by Alzheimer's disease
Burns, Christine , Kaszniak, Alfred W., Lee, Wendy , Alexander, Gene E. , Bandy, Daniel, Fleisher, Adam , Caselli, Richard J. , Reiman, Eric M. , Chen, Kewei

Mayo Clinic

Alzheimer's & Dementia | January 12, 2012 | Volume: 7 | Issue: 4S_Part_24 | Pages: No page available

10.1016/j.jalz.2011.09.024 Get It

P4‐472: Vasogenic edema in the setting of ß‐amyloid lowering therapy, adverse event: what is it and how is it detected?
Barakos, Jerome , Carlson, Christopher, Estergard, Wahiba, Oh, Joonmi, Suhy, Joyce, Siemers, Eric , Jack, Clifford R.

Mayo Clinic

Alzheimer's & Dementia | January 12, 2012 | Volume: 7 | Issue: 4S_Part_25 | Pages: No page available

10.1016/j.jalz.2011.09.165 Get It

Tissue Factor Pathway Inhibitor Blocks Angiogenesis via Its Carboxyl Terminus
Holroyd, Eric, Delacroix, Sinny , Larsen, Katarína, Harbuzariu, Adriana , Psaltis, Peter J. , Pan, Shuchong, White, Thomas A. , Witt, Tyra A. , Kleppe, Laurel S., Mueske, Cheryl S., Simari, Robert D., Wang, Ling , Mukhopadhyay, Debabrata

Mayo Clinic

Arteriosclerosis, Thrombosis, and Vascular Biology | January 6, 2012 | Volume: 32 | Issue: 3 | Pages: 704-711

10.1161/atvbaha.111.243733 | PMID 22223730 Get It

Objective— Tissue factor pathway inhibitor (TFPI) is the primary regulator of the tissue factor (TF) coagulation pathway. As such, TFPI may regulate the proangiogenic effects of TF. TFPI may also affect angiogenesis independently of TF, through sequences within its polybasic carboxyl terminus (TFPI C terminus [TFPIct]). We aimed to determine the effects of TFPI on angiogenesis and the role of TFPIct. Methods and Results— Transgenic overexpression of TFPI attenuated angiogenesis in the murine hindlimb ischemia model and an aortic sprout assay. In vitro, TFPI inhibited endothelial cell migration. Peptides within the human TFPIct inhibited endothelial cell cord formation and migration in response to vascular endothelial growth factor (VEGF) 165 but not VEGF121. Furthermore, exposure to human TFPIct inhibited the phosphorylation of VEGF receptor 2 at residue Lys951, a residue known to be critical for endothelial cell migration. Finally, systemic delivery of a murine TFPIct peptide inhibited angiogenesis in the hindlimb model. Conclusion— These data demonstrate an inhibitory role for TFPI in angiogenesis that is, in part, mediated through peptides within its carboxyl terminus. In addition to its known role as a TF antagonist, TFPI, via its carboxyl terminus, may regulate angiogenesis by directly blocking VEGF receptor 2 activation and attenuating the migratory capacity of endothelial cells.
Identification of a Monocyte-Predisposed Hierarchy of Hematopoietic Progenitor Cells in the Adventitia of Postnatal Murine Aorta
Psaltis, Peter J. , Harbuzariu, Adriana , Delacroix, Sinny , Witt, Tyra A. , Holroyd, Eric, Spoon, Daniel B., Hoffman, Scott J., Pan, Shuchong, Kleppe, Laurel S., Mueske, Cheryl S., Gulati, Rajiv , Sandhu, Gurpreet S. , Simari, Robert D.

Mayo Clinic

Circulation | December 28, 2011 | Volume: 125 | Issue: 4 | Pages: 592-603

10.1161/circulationaha.111.059360 | PMID 22203692 Get It

Background— Hematopoiesis originates from the dorsal aorta during embryogenesis. Although adult blood vessels harbor progenitor populations for endothelial and smooth muscle cells, it is not known if they contain hematopoietic progenitor or stem cells. Here, we hypothesized that the arterial wall is a source of hematopoietic progenitor and stem cells in postnatal life. Methods and Results— Single-cell aortic disaggregates were prepared from adult chow-fed C57BL/6 and apolipoprotein E–null (ApoE −/− ) mice. In short- and long-term methylcellulose-based culture, aortic cells generated a broad spectrum of multipotent and lineage-specific hematopoietic colony-forming units, with a preponderance of macrophage colony-forming units. This clonogenicity was higher in lesion-free ApoE −/− mice and localized primarily to stem cell antigen-1–positive cells in the adventitia. Expression of stem cell antigen-1 in the aorta colocalized with canonical hematopoietic stem cell markers, as well as CD45 and mature leukocyte antigens. Adoptive transfer of labeled aortic cells from green fluorescent protein transgenic donors to irradiated C57BL/6 recipients confirmed the content of rare hematopoietic stem cells (1 per 4 000 000 cells) capable of self-renewal and durable, low-level reconstitution of leukocytes. Moreover, the predominance of long-term macrophage precursors was evident by late recovery of green fluorescent protein–positive colonies from recipient bone marrow and spleen that were exclusively macrophage colony-forming units. Although trafficking from bone marrow was shown to replenish some of the hematopoietic potential of the aorta after irradiation, the majority of macrophage precursors appeared to arise locally, suggesting long-term residence in the vessel wall. Conclusions— The postnatal murine aorta contains rare multipotent hematopoietic progenitor/stem cells and is selectively enriched with stem cell antigen-1–positive monocyte/macrophage precursors. These populations may represent novel, local vascular sources of inflammatory cells.
Update on Exercise and Weight Control
King, Neil A. , Levine, James A. , Doucet, Éric , Ross, Robert R.

Mayo Clinic

Journal of Obesity | December 18, 2011 | Volume: 2011 | Issue: No issue available | Pages: 1-3

10.1155/2011/358205 | PMID 22220271 Get It

Productive Replication and Evolution of HIV-1 in Ferret Cells
Fadel, Hind J., Saenz, Dyana T. , Guevara, Rebekah B. , Messling, Veronika von , Peretz, Mary, Poeschla, Eric M.

Mayo Clinic

Journal of Virology | December 15, 2011 | Volume: 86 | Issue: 4 | Pages: 2312-2322

10.1128/jvi.06035-11 | PMID 22171279 Get It

ABSTRACT A rodent or other small animal model for HIV-1 has not been forthcoming, with the principal obstacles being species-specific restriction mechanisms and deficits in HIV-1 dependency factors. Some Carnivorans may harbor comparatively fewer impediments. For example, in contrast to mice, the domestic cat genome encodes essential nonreceptor HIV-1 dependency factors. All Feliformia species and at least one Caniformia species also lack a major lentiviral restriction mechanism (TRIM5α/TRIMCyp proteins). Here we investigated cells from two species in another carnivore family, the Mustelidae, for permissiveness to the HIV-1 life cycle. Mustela putorius furo (domesticated ferret) primary cells and cell lines did not restrict HIV-1, feline immunodeficiency virus (FIV), equine infectious anemia virus (EIAV), or N-tropic murine leukemia virus (MLV) postentry and supported late HIV-1 life cycle steps comparably to human cells. The ferret TRIM5α gene exon 8, which encodes the B30.2 domain, was found to be pseudogenized. Strikingly, ferret (but not mink) cells engineered to express human HIV-1 entry receptors supported productive spreading replication, amplification, and serial passage of wild-type HIV-1. Nevertheless, produced virions had relatively reduced infectivity and the virus accrued G→A hypermutations, consistent with APOBEC3 protein pressure. Ferret cell-passaged HIV-1 also evolved amino acid changes in the capsid cyclophilin A binding loop. We conclude that the genome of this carnivore can provide essential nonreceptor HIV-1 dependency factors and that ferret APOBEC3 proteins with activity against HIV-1 are likely. Even so, unlike in cat cells, HIV-1 can replicate in ferret cells without vif substitution. The virus evolves in this novel nonprimate cell adaptive landscape. We suggest that further characterization of HIV-1 adaptation in ferret cells and delineation of Mustelidae restriction factor repertoires are warranted, with a view to the potential for an HIV-1 animal model.
Next generation analytic tools for large scale genetic epidemiology studies of complex diseases
Mechanic, Leah E. , Chen, Huann‐Sheng , Chatterjee, Nilanjan , Cox, Nancy J. , Divi, Rao L., Fan, Ruzong , Harris, Emily , McAllister, Kimberly A. , Moore, Jason H. , Paltoo, Dina N., Province, Michael A. , Ramos, Erin M. , Ritchie, Marylyn D. , Roeder, Kathryn , Schaid, Daniel J. , Thomas, Duncan C. , Weinberg, Clarice R. , Witte, John S. , Zhang, Shunpu, Zöllner, Sebastian , Feuer, Eric J. , Gillanders, Elizabeth M. , Amos, Christopher I. , Jacobs, Kevin B. , Kraft, Peter , Leal, Suzanne M. , Stephens, Matthew , Weinberg, Clarice R , Province, Mike

Mayo Clinic

Genetic Epidemiology | December 6, 2011 | Volume: 36 | Issue: 1 | Pages: 22-35

10.1002/gepi.20652 | PMID 22147673 Get It

AbstractOver the past several years, genome‐wide association studies (GWAS) have succeeded in identifying hundreds of genetic markers associated with common diseases. However, most of these markers confer relatively small increments of risk and explain only a small proportion of familial clustering. To identify obstacles to future progress in genetic epidemiology research and provide recommendations to NIH for overcoming these barriers, the National Cancer Institute sponsored a workshop entitled “Next Generation Analytic Tools for Large‐Scale Genetic Epidemiology Studies of Complex Diseases” on September 15–16, 2010. The goal of the workshop was to facilitate discussions on (1) statistical strategies and methods to efficiently identify genetic and environmental factors contributing to the risk of complex disease; and (2) how to develop, apply, and evaluate these strategies for the design, analysis, and interpretation of large‐scale complex disease association studies in order to guide NIH in setting the future agenda in this area of research. The workshop was organized as a series of short presentations covering scientific (gene‐gene and gene‐environment interaction, complex phenotypes, and rare variants and next generation sequencing) and methodological (simulation modeling and computational resources and data management) topic areas. Specific needs to advance the field were identified during each session and are summarized.Genet. Epidemiol. 36 : 22–35, 2012. © 2011 Wiley Periodicals, Inc.
Methylphenidate
Prommer, Eric

Mayo Clinic

American Journal of Hospice and Palliative Medicine® | December 5, 2011 | Volume: 29 | Issue: 6 | Pages: 483-490

10.1177/1049909111427029 | PMID 22144657 Get It

Methylphenidate is a psychostimulant originally used for the treatment of attention-deficit disorder. Methylphenidate inhibits neuronal neurotransmitter transporters involved in the uptake of dopamine and norepinephrine at the level of the synapse. Inhibition of these transmitter transporters leads to increased concentrations of dopamine and norepinephrine in the synapse, which results in increasing alertness. The stimulant effect of methylphenidate has been used for the treatment of major depression, poststroke depression, cognitive enhancement in patients with brain tumors, neurodegenerative disorders, HIV disease, fatigue, and as a treatment for delirium and sedation associated with opioid use. Other areas where methylphenidate has been evaluated include gait disorders in the elderly individuals and the treatment of apathy in dementia. Analgesic effects have been demonstrated in preclinical models but true analgesic effects remain to be proven in humans. This article reviews the current use of methylphenidate for symptom management with a critical look at the evidence base for its efficacy in the conditions described.